SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-032070
Filing Date
2016-10-20
Accepted
2016-10-20 17:15:32
Documents
2
Period of Report
2016-10-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3933
2 EX-24 DOCUMENT attachment1.htm EX-24 4690
  Complete submission text file 0000899243-16-032070.txt   9930
Mailing Address ONYX PHARMACEUTICALS, INC. 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080
Business Address
CAGNONI PABLO J (Reporting) CIK: 0001205703 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37923 | Film No.: 161944887

Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 6173154600
CRISPR Therapeutics AG (Issuer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478
SIC: 2836 Biological Products, (No Diagnostic Substances)